ANDROGEL® Testosterone gel 1%

PrBIAXIN BID® Clarithromycin tablets

Pediatric PrBIAXIN® Clarithromycin suspension


For more information, visit Campral®, Product Catalogue.


Health Canada has deemed Clarus® bioequivalent to Accutane®. The Clarus® CLEAR Program provides information and support materials for Clarus® patients and healthcare professionals, such as pregnancy prevention checklists, patient monitoring charts, blood monitoring guides and patient reminder slips.

PrCREON MINIMICROSPHERES® Lipase/amylase/protease

PrDepakene® Valproic acid

PrDicetel® Pinaverium Bromide

PrDymista® Azelastine hydrochloride and fluticasone propionate

PrEpival® Divalproex sodium


Health Canada has deemed Gen-Clozapine bioequivalent to Clozaril®. Demonstrating Mylan’s commitment to patient safety, GenCAN is a national network designed to assist physicians and pharmacists in the registering and monitoring of Gen-Clozapine patients

DInfluvac® Influenza vaccine

DINFLUVAC®TETRA Quadrivalent influenza vaccine, surface antigen, inactivated

PrIsoptin®SR Verapamil hydrochloride sustained-release tablets

NKadian® Morphine sulphate pentahydrate

PrLipidil EZ® Fenofibrate, NanoCrystal® formulation

PrLipidil Supra® Fenofibrate, microcoated formulation

PrLuvox® Fluvoxamine maleate

PrMavik® Trandolapril Capsules

Mylan-Dexrazoxane 250 mg powder for Injection (US-labelled)

Due to a shortage in Canada, Pfizer Canada ULC has informed Health Canada that a steady supply of its ZINECARD (Dexrazoxane for Injection) is not expected until January 31, 2021. Given the medical necessity of this product, Health Canada has expressed no objection to the temporary importation and distribution of US-labelled Mylan-Dexrazoxane for Injection.

Important Safety Information

US-labelled Mylan Dexrazoxane Prescribing Information


To assist healthcare professionals and patients avoid exposure to Divalproex during pregnancy, please review the following educational materials as part of the Pregnancy Prevention Program.

HCP Guide

Physician Annual Risk Acknowledgement Form

Patient Annual Risk Acknowledgement Form

Patient Guide

Patient Card

For more information, visit Mylan-Divalproex, Product Catalogue


Health Canada has deemed Mylan-Fingolimod bioequivalent to Gilenya®.

Mylan-Fingolimod Patient Support Program:
Phone: 1-888-223-0038
Fax: 1-844-751-9982
Download the Enrollment form here

Mylan-Fingolimod Pregnancy Registry
Phone 1-888-246-5830; Fax 1-833-677-0484

Risk Mitigation Plan – Patient Reminder Card

Risk Mitigation Plan – Patient-Parent-Caregiver Guide

Risk Mitigation Plan – Educational Material for HCPs

PrPrevacid® FasTab Lansoprazole delayed-release tablets

PrPrevacid® Lansoprazole delayed-release capsules

PrRythmol® Propafenone hydrochloride film-coated tablets

PrSerc® Betahistinie dihydrochloride

PrSynthroid® Levothyroxine sodium tablets, USP

PrTarka® Trandolapril/verapamil hydrochloride sustained-release tablets

PrTOBI® PODHALER® Tobramycin Inhalation powder

PrTOBI® Tobramycin Inhalation solution, USP